Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 98

1.

CGRP-based Migraine Therapeutics: How Might They Work, Why So Safe, and What Next?

Russo AF.

ACS Pharmacol Transl Sci. 2019 Feb 8;2(1):2-8. doi: 10.1021/acsptsci.8b00036. Epub 2018 Nov 5.

PMID:
31559394
2.

Behavioral and cognitive animal models in headache research.

Vuralli D, Wattiez AS, Russo AF, Bolay H.

J Headache Pain. 2019 Jan 31;20(1):11. doi: 10.1186/s10194-019-0963-6. Review.

3.

CGRP in Animal Models of Migraine.

Wattiez AS, Wang M, Russo AF.

Handb Exp Pharmacol. 2019;255:85-107. doi: 10.1007/164_2018_187. Review.

PMID:
30689086
4.

Vascular Contributions to Migraine: Time to Revisit?

Mason BN, Russo AF.

Front Cell Neurosci. 2018 Aug 3;12:233. doi: 10.3389/fncel.2018.00233. eCollection 2018.

5.

Peripherally administered calcitonin gene-related peptide induces spontaneous pain in mice: implications for migraine.

Rea BJ, Wattiez AS, Waite JS, Castonguay WC, Schmidt CM, Fairbanks AM, Robertson BR, Brown CJ, Mason BN, Moldovan-Loomis MC, Garcia-Martinez LF, Poolman P, Ledolter J, Kardon RH, Sowers LP, Russo AF.

Pain. 2018 Nov;159(11):2306-2317. doi: 10.1097/j.pain.0000000000001337.

PMID:
29994995
6.

Current understanding of trigeminal ganglion structure and function in headache.

Messlinger K, Russo AF.

Cephalalgia. 2018 Jan 1:333102418786261. doi: 10.1177/0333102418786261. [Epub ahead of print]

PMID:
29989427
7.

Cortical spreading depression as a site of origin for migraine: Role of CGRP.

Close LN, Eftekhari S, Wang M, Charles AC, Russo AF.

Cephalalgia. 2019 Mar;39(3):428-434. doi: 10.1177/0333102418774299. Epub 2018 Apr 25.

PMID:
29695168
8.

Increased receptor activity-modifying protein 1 in the nervous system is sufficient to protect against autonomic dysregulation and hypertension.

Sabharwal R, Mason BN, Kuburas A, Abboud FM, Russo AF, Chapleau MW.

J Cereb Blood Flow Metab. 2019 Apr;39(4):690-703. doi: 10.1177/0271678X17751352. Epub 2018 Jan 3.

PMID:
29297736
9.

Overview of Neuropeptides: Awakening the Senses?

Russo AF.

Headache. 2017 May;57 Suppl 2:37-46. doi: 10.1111/head.13084. Review.

10.

CGRP receptor activity in mice with global expression of human receptor activity modifying protein 1.

Bohn KJ, Li B, Huang X, Mason BN, Wattiez AS, Kuburas A, Walker CS, Yang P, Yu J, Heinz BA, Johnson KW, Russo AF.

Br J Pharmacol. 2017 Jun;174(12):1826-1840. doi: 10.1111/bph.13783. Epub 2017 Apr 22.

11.

CGRP receptor antagonist activity of olcegepant depends on the signalling pathway measured.

Walker CS, Raddant AC, Woolley MJ, Russo AF, Hay DL.

Cephalalgia. 2018 Mar;38(3):437-451. doi: 10.1177/0333102417691762. Epub 2017 Feb 6.

12.

Induction of Migraine-Like Photophobic Behavior in Mice by Both Peripheral and Central CGRP Mechanisms.

Mason BN, Kaiser EA, Kuburas A, Loomis MM, Latham JA, Garcia-Martinez LF, Russo AF.

J Neurosci. 2017 Jan 4;37(1):204-216. doi: 10.1523/JNEUROSCI.2967-16.2016.

13.

Induction of calcitonin gene-related peptide expression in rats by cortical spreading depression.

Wang Y, Tye AE, Zhao J, Ma D, Raddant AC, Bu F, Spector BL, Winslow NK, Wang M, Russo AF.

Cephalalgia. 2019 Mar;39(3):333-341. doi: 10.1177/0333102416678388. Epub 2016 Nov 12.

PMID:
27919019
14.

Anti-CGRP antibodies block CGRP-induced diarrhea in mice.

Kaiser EA, Rea BJ, Kuburas A, Kovacevich BR, Garcia-Martinez LF, Recober A, Russo AF.

Neuropeptides. 2017 Aug;64:95-99. doi: 10.1016/j.npep.2016.11.004. Epub 2016 Nov 14.

15.

A second trigeminal CGRP receptor: function and expression of the AMY1 receptor.

Walker CS, Eftekhari S, Bower RL, Wilderman A, Insel PA, Edvinsson L, Waldvogel HJ, Jamaluddin MA, Russo AF, Hay DL.

Ann Clin Transl Neurol. 2015 Jun;2(6):595-608. doi: 10.1002/acn3.197. Epub 2015 Apr 1.

16.

CGRP as a neuropeptide in migraine: lessons from mice.

Russo AF.

Br J Clin Pharmacol. 2015 Sep;80(3):403-14. doi: 10.1111/bcp.12686. Epub 2015 Jul 14. Review.

17.

CGRP induction in cystic fibrosis airways alters the submucosal gland progenitor cell niche in mice.

Xie W, Fisher JT, Lynch TJ, Luo M, Evans TI, Neff TL, Zhou W, Zhang Y, Ou Y, Bunnett NW, Russo AF, Goodheart MJ, Parekh KR, Liu X, Engelhardt JF.

J Clin Invest. 2015 May;125(5):2179. doi: 10.1172/JCI82138. Epub 2015 May 1. No abstract available.

18.

Calcitonin gene-related peptide (CGRP): a new target for migraine.

Russo AF.

Annu Rev Pharmacol Toxicol. 2015;55:533-52. doi: 10.1146/annurev-pharmtox-010814-124701. Epub 2014 Oct 8. Review.

19.

Photophobia and abnormally sustained pupil responses in a mouse model of bradyopsia.

Kuburas A, Thompson S, Artemyev NO, Kardon RH, Russo AF.

Invest Ophthalmol Vis Sci. 2014 Sep 25;55(10):6878-85. doi: 10.1167/iovs.14-14784.

20.

Heat hyperalgesia and mechanical hypersensitivity induced by calcitonin gene-related peptide in a mouse model of neurofibromatosis.

White S, Marquez de Prado B, Russo AF, Hammond DL.

PLoS One. 2014 Sep 3;9(9):e106767. doi: 10.1371/journal.pone.0106767. eCollection 2014.

21.

Migraine meets membrane trafficking.

Russo AF.

Cephalalgia. 2014 Oct;34(11):851-2. doi: 10.1177/0333102414529194. Epub 2014 Apr 7. No abstract available.

PMID:
24711607
22.

Reactive oxygen species induce procalcitonin expression in trigeminal ganglia glia.

Raddant AC, Russo AF.

Headache. 2014 Mar;54(3):472-84. doi: 10.1111/head.12301. Epub 2014 Feb 11.

23.

CGRP and migraine: could PACAP play a role too?

Kaiser EA, Russo AF.

Neuropeptides. 2013 Dec;47(6):451-61. doi: 10.1016/j.npep.2013.10.010. Epub 2013 Oct 23. Review.

24.

Unanswered questions in headache: so what is photophobia, anyway?

Russo AF, Recober A.

Headache. 2013 Nov-Dec;53(10):1677-8. doi: 10.1111/head.12231. Epub 2013 Sep 23. Review. No abstract available.

25.

Amylin acts in the central nervous system to increase sympathetic nerve activity.

Fernandes-Santos C, Zhang Z, Morgan DA, Guo DF, Russo AF, Rahmouni K.

Endocrinology. 2013 Jul;154(7):2481-8. doi: 10.1210/en.2012-2172. Epub 2013 May 3.

26.

Protein inhibitors of activated STAT (Pias1 and Piasy) differentially regulate pituitary homeobox 2 (PITX2) transcriptional activity.

Wang J, Sun Z, Zhang Z, Saadi I, Wang J, Li X, Gao S, Engle JJ, Kuburas A, Fu X, Yu W, Klein WH, Russo AF, Amendt BA.

J Biol Chem. 2013 May 3;288(18):12580-95. doi: 10.1074/jbc.M112.374561. Epub 2013 Mar 20.

27.

Modulation of CGRP-induced light aversion in wild-type mice by a 5-HT(1B/D) agonist.

Kaiser EA, Kuburas A, Recober A, Russo AF.

J Neurosci. 2012 Oct 31;32(44):15439-49. doi: 10.1523/JNEUROSCI.3265-12.2012.

28.

Calcitonin gene-related peptide in migraine: intersection of peripheral inflammation and central modulation.

Raddant AC, Russo AF.

Expert Rev Mol Med. 2011 Nov 29;13:e36. doi: 10.1017/S1462399411002067. Review.

29.

CGRP induction in cystic fibrosis airways alters the submucosal gland progenitor cell niche in mice.

Xie W, Fisher JT, Lynch TJ, Luo M, Evans TI, Neff TL, Zhou W, Zhang Y, Ou Y, Bunnett NW, Russo AF, Goodheart MJ, Parekh KR, Liu X, Engelhardt JF.

J Clin Invest. 2011 Aug;121(8):3144-58. doi: 10.1172/JCI41857. Epub 2011 Jul 18. Erratum in: J Clin Invest. 2015 May;125(5):2179.

30.

Neuronal receptor activity-modifying protein 1 promotes energy expenditure in mice.

Zhang Z, Liu X, Morgan DA, Kuburas A, Thedens DR, Russo AF, Rahmouni K.

Diabetes. 2011 Apr;60(4):1063-71. doi: 10.2337/db10-0692. Epub 2011 Feb 25.

31.

Epigenetic regulation of the calcitonin gene-related peptide gene in trigeminal glia.

Park KY, Fletcher JR, Raddant AC, Russo AF.

Cephalalgia. 2011 Apr;31(5):614-24. doi: 10.1177/0333102410391487. Epub 2011 Jan 7.

32.

Light aversion in mice depends on nonimage-forming irradiance detection.

Thompson S, Recober A, Vogel TW, Kuburas A, Owens JA, Sheffield VC, Russo AF, Stone EM.

Behav Neurosci. 2010 Dec;124(6):821-7. doi: 10.1037/a0021568.

33.

Receptor activity-modifying protein-1 augments cerebrovascular responses to calcitonin gene-related peptide and inhibits angiotensin II-induced vascular dysfunction.

Chrissobolis S, Zhang Z, Kinzenbaw DA, Lynch CM, Russo AF, Faraci FM.

Stroke. 2010 Oct;41(10):2329-34. doi: 10.1161/STROKEAHA.110.589648. Epub 2010 Sep 2.

34.

Receptor activity-modifying protein 1 increases baroreflex sensitivity and attenuates Angiotensin-induced hypertension.

Sabharwal R, Zhang Z, Lu Y, Abboud FM, Russo AF, Chapleau MW.

Hypertension. 2010 Mar;55(3):627-35. doi: 10.1161/HYPERTENSIONAHA.109.148171. Epub 2010 Jan 25.

35.

Genetic enhancement of calcitonin gene-related Peptide-induced central sensitization to mechanical stimuli in mice.

Marquez de Prado B, Hammond DL, Russo AF.

J Pain. 2009 Sep;10(9):992-1000. doi: 10.1016/j.jpain.2009.03.018. Epub 2009 Jul 22.

36.

Induction of multiple photophobic behaviors in a transgenic mouse sensitized to CGRP.

Recober A, Kaiser EA, Kuburas A, Russo AF.

Neuropharmacology. 2010 Jan;58(1):156-65. doi: 10.1016/j.neuropharm.2009.07.009. Epub 2009 Jul 14.

37.

Role of calcitonin gene-related peptide in light-aversive behavior: implications for migraine.

Recober A, Kuburas A, Zhang Z, Wemmie JA, Anderson MG, Russo AF.

J Neurosci. 2009 Jul 8;29(27):8798-804. doi: 10.1523/JNEUROSCI.1727-09.2009.

38.

Calcitonin gene-related peptide: an update on the biology.

Recober A, Russo AF.

Curr Opin Neurol. 2009 Jun;22(3):241-6. Review.

39.

A Potential Preclinical Migraine Model: CGRP-Sensitized Mice.

Russo AF, Kuburas A, Kaiser EA, Raddant AC, Recober A.

Mol Cell Pharmacol. 2009;1(5):264-270.

40.

Anti-metallothionein IgG and levels of metallothionein in autistic families.

Russo AF.

Swiss Med Wkly. 2008 Feb 9;138(5-6):70-7.

PMID:
18365350
41.

Ramping it up: RAMP1 and the implications for migraine.

Russo AF.

Pharmacogenomics. 2007 Jul;8(7):687-90. doi: 10.2217/14622416.8.7.687. No abstract available.

42.

Control of the calcitonin gene-related peptide enhancer by upstream stimulatory factor in trigeminal ganglion neurons.

Park KY, Russo AF.

J Biol Chem. 2008 Feb 29;283(9):5441-51. doi: 10.1074/jbc.M708662200. Epub 2007 Dec 31.

43.

Olcegepant, a non-peptide CGRP1 antagonist for migraine treatment.

Recober A, Russo AF.

IDrugs. 2007 Aug;10(8):566-74.

PMID:
17665333
44.
45.

Nitric oxide regulation of calcitonin gene-related peptide gene expression in rat trigeminal ganglia neurons.

Bellamy J, Bowen EJ, Russo AF, Durham PL.

Eur J Neurosci. 2006 Apr;23(8):2057-66.

46.

An unusual class of PITX2 mutations in Axenfeld-Rieger syndrome.

Saadi I, Toro R, Kuburas A, Semina E, Murray JC, Russo AF.

Birth Defects Res A Clin Mol Teratol. 2006 Mar;76(3):175-81.

47.

CGRP receptor antagonists: A new frontier of anti-migraine medications.

de Prado BM, Russo AF.

Drug Discov Today Ther Strateg. 2006 Winter;3(4):593-597.

48.

Calcitonin gene-related peptide receptor activation by receptor activity-modifying protein-1 gene transfer to vascular smooth muscle cells.

Zhang Z, Dickerson IM, Russo AF.

Endocrinology. 2006 Apr;147(4):1932-40. Epub 2005 Dec 22.

PMID:
16373421
49.

Tumor necrosis factor-alpha stimulation of calcitonin gene-related peptide expression and secretion from rat trigeminal ganglion neurons.

Bowen EJ, Schmidt TW, Firm CS, Russo AF, Durham PL.

J Neurochem. 2006 Jan;96(1):65-77. Epub 2005 Nov 8.

50.

The effects of rest interval on quadriceps torque during an isokinetic testing protocol in elderly.

Bottaro M, Russo AF, de Oliveira RJ.

J Sports Sci Med. 2005 Sep 1;4(3):285-90. eCollection 2005 Sep 1.

Supplemental Content

Loading ...
Support Center